These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 36969584)

  • 1. The beneficial role of exercise in preventing doxorubicin-induced cardiotoxicity.
    Gaytan SL; Lawan A; Chang J; Nurunnabi M; Bajpeyi S; Boyle JB; Han SM; Min K
    Front Physiol; 2023; 14():1133423. PubMed ID: 36969584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise stimulates beneficial adaptations to diminish doxorubicin-induced cellular toxicity.
    Smuder AJ
    Am J Physiol Regul Integr Comp Physiol; 2019 Nov; 317(5):R662-R672. PubMed ID: 31461307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72.
    Kavazis AN; Smuder AJ; Min K; Tümer N; Powers SK
    Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1515-24. PubMed ID: 20833957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin-induced markers of myocardial autophagic signaling in sedentary and exercise trained animals.
    Smuder AJ; Kavazis AN; Min K; Powers SK
    J Appl Physiol (1985); 2013 Jul; 115(2):176-85. PubMed ID: 23703114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerobic Exercise Training as a Potential Cardioprotective Strategy to Attenuate Doxorubicin-Induced Cardiotoxicity.
    Kouzi SA; Uddin MN
    J Pharm Pharm Sci; 2016; 19(3):399-410. PubMed ID: 27806245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise during pregnancy decreases doxorubicin-induced cardiotoxic effects on neonatal hearts.
    Brito VB; Nascimento LV; Nunes RB; Moura DJ; Lago PD; Saffi J
    Toxicology; 2016 Aug; 368-369():46-57. PubMed ID: 27565713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Physical Exercise to Offset Anthracycline-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis of Clinical and Preclinical Studies.
    Naaktgeboren WR; Binyam D; Stuiver MM; Aaronson NK; Teske AJ; van Harten WH; Groen WG; May AM
    J Am Heart Assoc; 2021 Sep; 10(17):e021580. PubMed ID: 34472371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective Effect of Phase 3 Clinical Anticancer Agent, RRx-001, in Doxorubicin-Induced Acute Cardiotoxicity in Mice.
    Oronsky B; Ao-Ieong ESY; Yalcin O; Carter CA; Cabrales P
    Mol Pharm; 2019 Jul; 16(7):2929-2934. PubMed ID: 31038318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Cardioprotection Reduces Mortality in Lymphoma Patients with Increased Risk of Anthracycline Cardiotoxicity, Treated by R-CHOP Regimen.
    Długosz-Danecka M; Gruszka AM; Szmit S; Olszanecka A; Ogórka T; Sobociński M; Jaroszyński A; Krawczyk K; Skotnicki AB; Jurczak W
    Chemotherapy; 2018; 63(4):238-245. PubMed ID: 30372698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Effect of Crocin on Doxorubicin-Induced Cardiotoxicity.
    Motlagh PE; Novin AG; Ghahari F; Nikzad A; Khoshandam M; Mardani S; Khanbabaei H; Farsinejad A; Sathyapalan T; Sahebkar A; Pourghadamyari H
    Adv Exp Med Biol; 2021; 1328():143-153. PubMed ID: 34981476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics.
    Arinno A; Maneechote C; Khuanjing T; Ongnok B; Prathumsap N; Chunchai T; Arunsak B; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Biochem Pharmacol; 2021 Oct; 192():114743. PubMed ID: 34453902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardioprotective effects of nano-curcumin against doxorubicin-induced cardiotoxicity: A systematic review.
    Moutabian H; Ghahramani-Asl R; Mortezazadeh T; Laripour R; Narmani A; Zamani H; Ataei G; Bagheri H; Farhood B; Sathyapalan T; Sahebkar A
    Biofactors; 2022 May; 48(3):597-610. PubMed ID: 35080781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity.
    Schwach V; Slaats RH; Passier R
    Front Cardiovasc Med; 2020; 7():50. PubMed ID: 32322588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB
    Meeran MFN; Al Taee H; Azimullah S; Tariq S; Adeghate E; Ojha S
    Chem Biol Interact; 2019 May; 304():158-167. PubMed ID: 30836069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity.
    Abushouk AI; Ismail A; Salem AMA; Afifi AM; Abdel-Daim MM
    Biomed Pharmacother; 2017 Jun; 90():935-946. PubMed ID: 28460429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of trastuzumab induced cardiotoxicity - is exercise a potential treatment?
    Eaton H; Timm KN
    Cardiooncology; 2023 Apr; 9(1):22. PubMed ID: 37098605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
    Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological interventions for preventing anthracycline-induced clinical and subclinical cardiotoxicity: A network meta-analysis of metastatic breast cancer.
    Ghasemi K; Vaseghi G; Mansourian M
    J Oncol Pharm Pract; 2021 Mar; 27(2):414-427. PubMed ID: 33081570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches.
    Sheibani M; Azizi Y; Shayan M; Nezamoleslami S; Eslami F; Farjoo MH; Dehpour AR
    Cardiovasc Toxicol; 2022 Apr; 22(4):292-310. PubMed ID: 35061218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine.
    Cheah IK; Tang RMY; Wang X; Sachaphibulkij K; Chong SY; Lim LHK; Wang JW; Halliwell B
    Antioxidants (Basel); 2023 Jan; 12(2):. PubMed ID: 36829879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.